Glicron CR Capsule 30 mg is a controlled-release formulation containing Gliclazide, an effective oral antidiabetic agent for the management of type 2 diabetes mellitus. The controlled-release (CR) technology ensures gradual release of the active ingredient, providing sustained blood sugar control throughout the day with fewer doses. Gliclazide belongs to the sulfonylurea class and works by stimulating insulin secretion from the pancreas and improving glucose utilization in the body, helping patients maintain stable blood sugar levels and reduce the risk of diabetes-related complications.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Glicron CR Capsule 30 mg is indicated for:
Type 2 diabetes mellitus – To achieve and maintain optimal glycemic control when diet and lifestyle measures are insufficient.
Adjunct therapy – Can be used alongside other antidiabetic medications or insulin under medical supervision.
Prevention of diabetic complications – Consistent blood sugar control helps reduce the risk of heart, kidney, nerve, and eye complications.
Gliclazide in a controlled-release form works by:
Stimulating pancreatic insulin secretion – Enhances insulin release in response to elevated blood glucose levels.
Reducing hepatic glucose production – Lowers fasting blood sugar levels.
Improving peripheral glucose utilization – Helps body tissues efficiently absorb and use glucose.
The controlled-release design ensures a steady and prolonged effect, reducing peaks and troughs in blood sugar levels and minimizing the risk of hypoglycemia.
Recommended dose: Usually 30–120 mg once daily with breakfast or as directed by a healthcare professional.
Administration: Swallow the capsule whole with water; do not crush or chew, as this may affect the controlled-release mechanism.
Monitoring: Regular blood sugar monitoring is essential to adjust dosage and ensure optimal glycemic control.
Hypoglycemia risk: Patients should be aware of symptoms like dizziness, sweating, and confusion. Keep glucose tablets or sugary snacks handy.
Kidney or liver impairment: Dose adjustment may be necessary in patients with renal or hepatic conditions.
Pregnancy and breastfeeding: Use only under medical supervision.
Drug interactions: Inform your doctor about all medications being taken to avoid reduced efficacy or increased side effects.
Common side effects include:
Low blood sugar (hypoglycemia)
Nausea or mild gastrointestinal discomfort
Headache or dizziness
Weight gain in some patients
Adherence to dosage and proper diet reduces the risk of side effects. Severe hypoglycemia requires immediate medical attention.
Store Glicron CR Capsule 30 mg in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Glicron CR Capsule 30 mg by SK Pharma offers effective and sustained blood sugar control for patients with type 2 diabetes. Its controlled-release formulation ensures steady insulin stimulation and optimal glycemic management, reducing the risk of daily glucose fluctuations and long-term complications. Regular monitoring, proper diet, and medical supervision enhance its safety and efficacy.
Login Or Registerto submit your questions to seller
No none asked to seller yet